Drug Shortage Report for HALOPERIDOL INJECTION

Last updated on 2025-11-29 History
Report ID 270024
Drug Identification Number 02366010
Brand name HALOPERIDOL INJECTION
Common or Proper name HALOPERIDOL INJECTION 5MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 1 mL vial / fiole
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-10-21
Estimated end date 2026-12-12
Actual end date 2025-11-28
Shortage status Resolved
Updated date 2025-11-29
Company comments Stock available at CPDN
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-11-29 English Compare
v9 2025-11-28 French Compare
v8 2025-11-28 English Compare
v7 2025-11-27 French Compare
v6 2025-11-27 English Compare
v5 2025-11-19 French Compare
v4 2025-11-19 English Compare
v3 2025-10-22 English Compare
v2 2025-10-21 French Compare
v1 2025-10-21 English Compare

Showing 1 to 10 of 10